Fibrate-statin combinations with reduced fed-fasted effects

Details for Australian Patent Application No. 2001259099 (hide)

Owner SkyePharma Canada Inc.

Inventors Snow, Robert A.; Parikh, Indu; Guivarc'h, Pol-Henri

Agent Peter Maxwell & Associates

Pub. Number AU-B-2001259099

PCT Pub. Number WO2002/067901

Priority 60/270,157 22.02.01 US

Filing date 20 April 2001

Wipo publication date 12 September 2002

Acceptance publication date 22 December 2005

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/216 (2006.01)

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

Event Publications

6 March 2003 Application Open to Public Inspection

  Published as AU-B-2001259099

22 December 2005 Application Accepted

  Published as AU-B-2001259099

27 April 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001259100

2001259098